Delivery Order SPE2DB20D2104-SPE2DB25FNBDY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $4,560.54. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Eliquis 5 mg tablets (60-count units) at a firm fixed price ceiling value of $25,069.77. This non-set-aside, competitively awarded contract is scheduled for completion by August 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $42,178.80. This firm fixed-price delivery order, which is set to be completed by July 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $2,635.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by May 2, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $25,897.33. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on September 10, 2025, with a ceiling value of $12,412.98 under a firm fixed-price contract. This award represents a non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a contract ceiling value of $55,353.92. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 20, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The work will be performed at the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a contract ceiling value of $7,458.91. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order is scheduled for completion by August 11, 2025, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $7,131.73. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for ultimate completion by August 27, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBDYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This non-competitive, firm fixed-price delivery order carries a ceiling value of $11,411.02 and is scheduled for completion by September 23, 2025. The award represents a fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to distribute a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor with an extensive portfolio of delivery orders through the DLA Medical Supply Chain. The company serves multiple federal customers, including the Defense Health Agency and U.S. Coast Guard, supplying brand-name and generic medications, vaccines, and specialized medical commodities across numerous therapeutic domains. This delivery order for Eliquis, an anticoagulant medication, exemplifies the company's role in providing essential pharmaceutical products to support military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 9/22/25 |